BridgeMD
Compares treatment options for Chronic Obstructive Pulmonary Disease (COPD)
Official title Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
ClinicalTrials.gov ID: NCT06892210
What this study is testing
What is Methylprednisolone (drug)?
Methylprednisolone (drug) is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for chronic obstructive pulmonary disease (copd).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this cluster randomized controlled trial is to determine the optimal treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 40 years old diagnosed with chronic obstructive pulmonary disease with acute exacerbation.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Age ≥40 years
- Chronic obstructive pulmonary disease with acute exacerbation, unspecified: ICDJ44
You likely can't join if
- All diagnoses that would merit treatment with a specific corticosteroid
- Pregnant or breastfeeding women
- Active tuberculosis or invasive fungal infection
The study team makes the final eligibility decision.
Where it's taking place
- Rønne, Bornholm, Denmark
- Copenhagen, Copenhagen City, Denmark
- Frederiksberg, Copenhagen City, Denmark
- Hellerup, Copenhagen City, Denmark
- Herlev, Copnhagen Surroundings, Denmark
- Hvidovre, Copnhagen Surroundings, Denmark
- Hillerød, North Zealand, Denmark
- Holbæk, Region Sjælland, Denmark
- Køge, Region Sjælland, Denmark
- Næstved, Region Sjælland, Denmark
- Ringsted, Region Sjælland, Denmark
- Roskilde, Region Sjælland, Denmark
- Slagelse, Region Sjælland, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rønne, Bornholm, Denmark; Copenhagen, Copenhagen City, Denmark; Frederiksberg, Copenhagen City, Denmark; Hellerup, Copenhagen City, Denmark; Herlev, Copnhagen Surroundings, Denmark; Hvidovre, Copnhagen Surroundings, Denmark and 7 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.